Voya VP International Index Portfolio S (INTIX)
14.84
-0.01
(-0.07%)
USD |
Oct 05 2026
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.70% | 690.98M | 2.43% | 4.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 48.69M | 12.54% |
Basic Info
| Investment Strategy | |
| The Portfolio seeks results that correspond to the total return of the Morgan Stanley Capital International Europe, Australia and Far East Index which is a market value-weighted index that reflects the performance of approximately 1,100 securities listed on the stock exchanges of Europe, Australasia and the Far East. |
| General | |
| Security Type | Insurance Fund |
| Equity Style | Large Cap Core |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Voya |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
52
-695.09M
Peer Group Low
5.174B
Peer Group High
1 Year
% Rank:
28
48.69M
-7.501B
Peer Group Low
9.295B
Peer Group High
3 Months
% Rank:
51
-2.494B
Peer Group Low
5.841B
Peer Group High
3 Years
% Rank:
83
-10.21B
Peer Group Low
14.64B
Peer Group High
6 Months
% Rank:
20
-4.411B
Peer Group Low
6.787B
Peer Group High
5 Years
% Rank:
75
-9.149B
Peer Group Low
19.21B
Peer Group High
YTD
% Rank:
22
-6.212B
Peer Group Low
8.194B
Peer Group High
10 Years
% Rank:
78
-33.44B
Peer Group Low
37.53B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of October 06, 2026.
Asset Allocation
As of August 31, 2026.
| Type | % Net |
|---|---|
| Cash | -1.64% |
| Stock | 96.68% |
| Bond | 0.16% |
| Convertible | 0.00% |
| Preferred | 0.22% |
| Other | 4.58% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| ASML Holding NV | 2.92% | 1867.34 | -1.12% |
|
MSCI EAFE SEP6
|
2.90% | -- | -- |
|
ICICI PRU FM SR 81 1116 D DIR CUM CF
|
1.54% | -- | -- |
| Roche Holding AG | 1.36% | 427.89 | -0.08% |
| Novartis AG | 1.24% | 134.53 | 0.25% |
| Shell Plc | 1.12% | 46.61 | -1.38% |
| Nestlé SA | 1.11% | 89.84 | -0.47% |
| Siemens AG | 1.09% | 309.53 | 0.08% |
| Mitsubishi UFJ Financial Group, Inc. | 1.08% | 23.66 | 0.75% |
| AstraZeneca PLC | 1.07% | 158.58 | 1.31% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.25% |
| Actual Management Fee | 0.34% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product |
|
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 0.00 None |
| Minimum Subsequent Investment | 0.00 None |
TTM Distributions
| Type | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of September 30, 2026.
Basic Info
| Investment Strategy | |
| The Portfolio seeks results that correspond to the total return of the Morgan Stanley Capital International Europe, Australia and Far East Index which is a market value-weighted index that reflects the performance of approximately 1,100 securities listed on the stock exchanges of Europe, Australasia and the Far East. |
| General | |
| Security Type | Insurance Fund |
| Equity Style | Large Cap Core |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Voya |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (10-5-26) | 3.62% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 691 |
| Stock | |
| Weighted Average PE Ratio | 24.42 |
| Weighted Average Price to Sales Ratio | 3.974 |
| Weighted Average Price to Book Ratio | 4.946 |
| Weighted Median ROE | 19.79% |
| Weighted Median ROA | 6.92% |
| Return on Investment (TTM) | 13.05% |
| Earning Yield | 0.0554 |
| LT Debt / Shareholders Equity | 0.7842 |
| Number of Equity Holdings | 671 |
As of August 31, 2026
Growth Metrics
| EPS Growth (1Y) | 19.59% |
| EPS Growth (3Y) | 12.31% |
| EPS Growth (5Y) | 17.45% |
| Sales Growth (1Y) | 6.42% |
| Sales Growth (3Y) | 5.83% |
| Sales Growth (5Y) | 9.10% |
| Sales per Share Growth (1Y) | 8.37% |
| Sales per Share Growth (3Y) | 7.32% |
| Operating Cash Flow - Growth Rate (3Y) | 13.06% |
As of August 31, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |